By Gerelyn Terzo, Global AgInvesting Media
Dutch food-tech startup Revyve has secured €24 million in a Series B fundraising, catapulting its total fundraising tally to over €40 million. Revyve is behind egg-replacing yeast proteins, an animal-free, single-ingredient solution targeting bakery, snacks and plant-based meat makers. Proceeds will be directed toward expanding manufacturing capacity and accelerating upcoming commercial launches of functional yeast proteins meant to replace real eggs and additives that are common in food production. Revyve’s mission is to overhaul the alternative protein space with a next-gen clean-label solution.
Co-led by ABN AMRO’s Sustainable Impact Fund and Invest-NL, the round also extended to regional backer Brabantse Ontwikkelings Maatschappij as well as Lallemand Bio-Ingredients’ Swiss affiliate Danstar Ferment and Grey Silo Ventures. Existing backers Oost NL and Royal Cosun also joined the investor lineup for this round.
ABN AMRO SIF Senior Investment Manager Hanna Zwietering commented, “We are excited to partner with Revyve as they pioneer pressing sustainable alternatives to traditional egg ingredients. Their solution addresses a critical need in the food transition: scalable ingredients with a low environmental footprint and compelling economics for food manufacturers. We believe this combination of commercial viability and measurable sustainable benefits makes Revyve uniquely positioned to grow into a global leader. We look forward to supporting their journey.”
Revyve offers yeast-based proteins designed to replicate the functional properties of eggs across diverse applications, including bakery, sauces, alternative meats and plant-based dairy. Made from yeast that mimics the functionality of eggs, these proteins provide a natural alternative that maintains nutritional integrity while reducing reliance on animal-derived components. The company is positioning its solutions to confront issues in the food industry, from volatile commodity prices to demands for transparency and environmental accountability.
Revyve CEO Cedric Verstraeten stated, “Food manufacturers are cutting back on eggs to offset increasing prices and reach sustainability targets, but replicating their unique functionality is crucial to maintaining the texture and mouthfeel consumers are used to. This is exactly where our Yeast Proteins come in, providing an affordable and clean label solution for egg replacement or egg reduction. This funding round marks a tipping point for us: allowing us to modularly scale production and branch out to more food categories and serve our sustainable solutions to larger customers worldwide”
Last year, Revyve achieved a milestone by launching its innovative production plant in Wageningen and Dinteloord, Central Netherlands, a facility that has quickly proven its mettle in churning out large-scale batches of yeast-derived proteins. Humming at maximum capacity to meet orders, the site has strengthened the firm’s market preparedness amid growing demand for eco-conscious, egg-replicating components in the food sector. Fueled by recent capital infusion, the planned growth will boost production beyond 1,600 tons each year.
As industrial-scale production gains momentum, Revyve has established a foothold with clients spanning Europe, the U.K., the U.S., Canada, Mexico and Australia, delivering its yeast-derived proteins to food innovators worldwide.
The content put forth by Global AgInvesting News and its parent company HighQuest Partners is intended to be used and must be used for informational purposes only. All information or other material herein is not to be construed as legal, tax, investment, financial, or other advice. Global AgInvesting and HighQuest Partners are not a fiduciary in any manner, and the reader assumes the sole responsibility of evaluating the merits and risks associated with the use of any information or other content on this site.